TERCONAZOLE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for terconazole and what is the scope of patent protection?

Terconazole is the generic ingredient in three branded drugs marketed by Janssen Pharms, Fougera Pharms, Fougera Pharms Inc, Taro, and Padagis Israel, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for terconazole. Eight suppliers are listed for this compound.

Sponsor	Phase
Hatem AbuHashim	N/A
Assiut University	Phase 3
Curatek Pharmaceuticals, LLC	Phase 3

Sponsor

Phase

Hatem AbuHashim

N/A

Assiut University

Phase 3

Curatek Pharmaceuticals, LLC

Phase 3

US Patents and Regulatory Information for TERCONAZOLE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Janssen Pharms	TERAZOL 3	terconazole	SUPPOSITORY;VAGINAL	019641-001	May 24, 1988		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Janssen Pharms	TERAZOL 3	terconazole	CREAM;VAGINAL	019964-001	Feb 21, 1991		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Taro	TERCONAZOLE	terconazole	CREAM;VAGINAL	076043-001	Jan 19, 2005	AB	RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Fougera Pharms Inc	TERCONAZOLE	terconazole	CREAM;VAGINAL	021735-001	Oct 1, 2004	BX	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Padagis Israel	TERCONAZOLE	terconazole	SUPPOSITORY;VAGINAL	077149-001	Mar 17, 2006	AB	RX	No	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Fougera Pharms	TERCONAZOLE	terconazole	CREAM;VAGINAL	076712-001	Feb 18, 2005	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Janssen Pharms	TERAZOL 3	terconazole	CREAM;VAGINAL	019964-001	Feb 21, 1991	⤷ Sign Up	⤷ Sign Up
Janssen Pharms	TERAZOL 3	terconazole	SUPPOSITORY;VAGINAL	019641-001	May 24, 1988	⤷ Sign Up	⤷ Sign Up
Janssen Pharms	TERAZOL 7	terconazole	CREAM;VAGINAL	019579-001	Dec 31, 1987	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Applicant

Tradename

Generic Name

Dosage

NDA

Approval Date

Patent No.

Patent Expiration

CREAM;VAGINAL

Feb 21, 1991

⤷ Sign Up

SUPPOSITORY;VAGINAL

May 24, 1988

⤷ Sign Up

CREAM;VAGINAL

Dec 31, 1987

⤷ Sign Up

>Applicant

>Tradename

>Generic Name

>Dosage

>NDA

>Approval Date

>Patent No.

>Patent Expiration

Subscribe to access the full database, or Sign Up

US Patents:	0
Tradenames:	3
Applicants:	5
NDAs:	10
Drug Master File Entries:	6
Finished Product Suppliers / Packagers:	8
Raw Ingredient (Bulk) Api Vendors:	59
Clinical Trials:	8
Patent Applications:	5,623
Drug Prices:	Drug price trends for TERCONAZOLE
What excipients (inactive ingredients) are in TERCONAZOLE?	TERCONAZOLE excipients list
DailyMed Link:	TERCONAZOLE at DailyMed

TERCONAZOLE - Generic Drug Details

What are the generic sources for terconazole and what is the scope of patent protection?

Summary for TERCONAZOLE

Recent Clinical Trials for TERCONAZOLE

Pharmacology for TERCONAZOLE

Anatomical Therapeutic Chemical (ATC) Classes for TERCONAZOLE

US Patents and Regulatory Information for TERCONAZOLE

Expired US Patents for TERCONAZOLE

Make Better Decisions: Try a trial or see plans & pricing